A mutation in isocitrate dehydrogenase 1 was found to suppress the transforming growth factor-beta signaling pathway and E2F4 interacted with Smad3 to inhibit expression of mesenchymal markers.
[Oncogenesis]
Sorry, but the selected Zotpress account can't be found.
